Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway
Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway is a paper indexed in PICO Portal from OpenAlex.
How many citations does Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway have?
Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway has 89 citations in the OpenAlex counts PICO Portal stores.
When was Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway published?
Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway has 2015 year in the PICO Portal index.
What is the open-access status of Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway?
Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway has bronze oa status in the PICO Portal index.
What is the DOI of Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway?
The DOI for Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway is on the source record.
What is the PMID of Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway?
The PMID for Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway is on the source record.
What is the OpenAlex record for Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway?
The OpenAlex for Tetramethylpyrazine reduces inflammation in liver fibrosis and inhibits inflammatory cytokine expression in hepatic stellate cells by modulating <scp>NLRP</scp>3 inflammasome pathway is on the source record.